Argos

Argos finds silver lining for I/O candidate
BioPharma Dive
Tue, 11/14/17 - 07:55 pm
Argos
immuno-oncology
rocapuldencel-T
Argos’ PhIII for its personalized cancer vaccine implodes during an interim analysis
Endpoints
Wed, 02/22/17 - 09:49 am
Argos
personalized medicine
vaccines
rocapuldencel-T
renal cell carcinoma
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Fierce Biotech
Tue, 12/31/13 - 11:42 am
Argos
IPOs
Dendreon
AGS-003
personalized medicine
renal cell carcinoma
IPO Preview: Argos Therapeutics
Seeking Alpha
Wed, 02/29/12 - 10:05 am
IPOs
Argos
GSK
Novartis
Pfizer
ONYX Pharmaceuticals
Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
BNET Pharma
Mon, 05/24/10 - 08:03 am
Avastin
Nektar
Sunesis
ASCO
cancer
vaccines
personalized medicine
ovarian cancer
Celgene
Revlimid
Rituxan
Roche
Dendreon
Provenge
Celldex
Pfizer
Argos
Plexxikon